Alaunos Therapeutics, Inc. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
Alaunos Therapeutics, Inc. (TCRT) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 5.01% for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-03.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2014-03-03
- Alaunos Therapeutics, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2013 was 5.01%, a 0.00% change from fiscal 2012.
- Alaunos Therapeutics, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2012 was 5.01%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month |
|---|---|
| 2013-12-31 | 5.01% 10-K · filed 2014-03-03 |
| 2012-12-31 | 5.01% 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |